top of page


Public·13 members
Xiao Peng
Xiao Peng
February 6, 2024 · joined the group.
Evelyn Argirokastritis
October 3, 2023 · joined the group.
Industry Member
October 26, 2022 · joined the group.
Recognizes the time and energy devoted to leading key NICER committees.Committee Chair
Steering Committee MemberSteering Committee

Sharing on behalf of Dr. Kim Nichols,

Dear NICER colleagues, In collaboration with the North American Consortium for Histiocytosis (NACHO), Melissa Hines and I are running a clinical trial investigating the efficacy and tolerability of a response-adapted ruxolitinib-containing regimen for children with newly diagnosed or relapsed/refractory HLH. The protocol is now open at 10 participating sites, including:

  • St. Jude Children’s Research Hospital – Memphis, TN

  • Children’s Hospital of Philadelphia – Philadelphia, PA


Welcome to the NICER Cytopenia Forum! As cytopenias are beco...


bottom of page